Microtech, a subsidiary of Medinol Inc. specializing in MedTech research and development, began the human clinical trials of its advanced microsensors platform. The trial focuses on measuring atrial pressure, which is essential for managing heart failure, and the first implantation was recently carried out at the Beilinson Medical Center in Petah-Tikva, Israel.
Microtech's implantable microsensor platform represents years of innovation in a new sensor technology. This device can function as an autonomous unit or be integrated into existing medical devices. Thanks to its extremely small . . .
🔒 Cet article est réservé aux abonnés. Inscrivez-vous pour lire la suite !
